About The Medical Condition Drug Evaluation, FDA Phase 1
Find the definition of the medical term Drug Evaluation, FDA Phase 1. Drug Evaluation, FDA Phase 1 defined and explained for easy understanding at the Medical Conditions from ClusterMed.info.
Drug Evaluation, FDA Phase 1
| Drug Evaluation, FDA Phase 1 Medical Condition |
|---|
What's The Definition Of The Medical Condition Drug Evaluation, FDA Phase 1?
Studies performed to evaluate the safety of diagnostic, therapeutic, or prophylactic drugs, devices, or techniques in healthy subjects and to determine the safe dosage range (if appropriate). These tests also are used to determine pharmacologic and pharmacokinetic properties (toxicity, metabolism, absorption, elimination, and preferred route of administration). They involve a small number of persons and usually last about 1 year. This concept includes phase I studies conducted both in the U.S. and in other countries.
|
More Medical Conditions
A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Medical Conditions Definitions Of The Day
- Processes, Copying ‐ Reproduction of data in a new location or other destination,…
- Techniques, Neurological Diagnostic ‐ Methods and procedures for the diagnosis of diseases of the nervous…
- Niridazole ‐ An antischistosomal agent that has become…
- Inositol Phospholipids ‐ Derivatives of phosphatidic acids in which the phosphoric acid…
- Spontaneous Rupture ‐ Tear or break of an organ, vessel or other soft part of the body,…
- Iododeoxyuridine ‐ An analog of DEOXYURIDINE that inhibits viral DNA synthesis.…
- Pharynx Cancers ‐ Tumors or cancer of…
- Frozen Section ‐ Thinly cut sections of frozen tissue specimens prepared with…
- Myosin V1 ‐ Myosin type II isoforms specifically found in the ventricular…
- Pathways, Efferent ‐ Nerve structures through which impulses are conducted from a…